Schedule 13G ownership disclosure
Radiopharm Theranostics Ltd
Ordinary Shares, as represented by American Depositary Shares · CUSIP: Q79455103
Event date: 2025-12-31
- Filing-level shares
- 145,679,951
- Percent of class
- 4.0%
- JPMORGAN CHASE & CO.
Shares: 145,679,951 · Class: 4.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-26-000027
- Form type
- SCHEDULE 13G/A
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Jan 16, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership